Publication

Article

Pharmacy Times
November 2013 Cough & Cold
Volume 79
Issue 11

Health App Wrap

Epocrates, maker of the popular medical reference app, offers a mobile app to track antimicrobial susceptibility and bacterial resistance data in a pharmacist’s area and allow informed decisions at the point of care. The resistance data, which are typically gathered from in-patient records, are sourced from athenahealth’s cloud-based electronic health record, which includes more than 15 million patient records. The app records bacteria detected in urine, in blood, or on skin, and includes geolocated information as to prevalence within the community. In addition, Epocrates Bugs + Drugs supplies antibiotic drug options that are organized by organism susceptibility. The antibiotic drug options include dosing and contraindication content with links to the complete drug monographs. Content for antibiotic selections are sourced from Epocrates’ drug reference, and, if the user has Epocrates Rx on his or her device, Bugs + Drugs will link to the prescribing reference app. The app provides 1-tap access to a visual listing of bacteria observed in the user’s area. In addition, users can filter listings by specimen type, or change their location to a different zip code if they are working in a different location. Epocrates Bugs + Drugs is compatible with iPhone, iPad, and iPod touch, though users should note that the app requires iOS 7.0 or later.

Cost: Free

Compatible With: iPhone, iPad, iPod touch.

Download: http://phrmcyt.ms/1byjMaq

Designed to boost positive emotions, increase self-efficacy, and shift attitudes about cancer treatment, Re-Mission 2: Nanobot’s Revenge places young patients on the offensive in this online and mobile game. As a microscopic robot battling cancer cells, patients can chose from chemo, radiation, and targeted cancer drug attacks to destroy tumor cells. The free app includes 12 playable levels, unlockable attacks, an achievement system that can be used to purchase character upgrades, and an unlockable challenge level.

Cost: Free

Compatible With: Android devices, iPhone, iPod touch, iPad

Download: Android: http://phrmcyt.ms/15HU0Qn; iTunes: http://phrmcyt.ms/15HU6Hq

MedDiary, a chronic disease management app, includes a built-in library of 12 disease management plans that allows patients to quickly and easily create personalized health plans. It supports multiple chronic diseases as well, negating the need for multiple disease-specific apps. Its features include a food diary, a medication diary, medication reminders, a symptom diary, and a test events diary. In addition, MedDiary develops PDF reports and offers the ability to share reports with health care providers through MedDiary’s secure website.

Cost: Free

Compatible With: iPhone, iPad, iPod touch

Download: http://phrmcyt.ms/15HUHsE

Feedly allows users to organize their favorite health blogs, news sites, and YouTube channels in 1 easy-to-access place on the user’s Apple or Android device. The device formats websites as easy-to-read cards and allows users to save articles to share on Twitter, Facebook, or other social networks. Feedly supports installation and syncing on multiple devices, so users can maintain their place regardless of the device on which they’re reading.

Cost: Free

Compatible With: Android devices, iPhone, iPad, iPod touch

Download: Android: http://phrmcyt.ms/15HWSg0; iTunes: http://phrmcyt.ms/15HWPAX

Top 200 Drugs Quiz & Card allows pharmacy professionals and pharmacy students to review pertinent information about the top 200 prescribed drugs. Entries include brand and generic drug names, therapeutic class, primary indication, and popularity. The flashcard feature generates review cards from the full drug list or a customized favorites list, and the quiz feature can generate up to 2000 questions per quiz.

Cost: $1.99

Compatible With: Android devices, iPhone, iPad, iPod touch

Download: Android: http://phrmcyt.ms/15I3JGc; iTunes: http://phrmcyt.ms/15I3LOg

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs